Nabriva's Antibiotic Contempo Turned Down by FDA Over Manufactu...

05/01/19

Nabriva's Antibiotic Contempo Turned Down by FDA Over Manufacturing Issues  BioSpace

Nabriva Therapeutics announced that the Food and Drug Administration (FDA) had issued a Complete Response Letter (CRL) for its New Drug Application ...

[more]